123 related articles for article (PubMed ID: 25695890)
1. Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations.
Sipos B; Sperveslage J; Anlauf M; Hoffmeister M; Henopp T; Buch S; Hampe J; Weber A; Hammel P; Couvelard A; Höbling W; Lieb W; Boehm BO; Klöppel G
J Clin Endocrinol Metab; 2015 May; 100(5):E783-8. PubMed ID: 25695890
[TBL] [Abstract][Full Text] [Related]
2. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.
Gild ML; Tsang V; Samra J; Clifton-Bligh RJ; Tacon L; Gill AJ
J Clin Endocrinol Metab; 2018 Sep; 103(9):3119-3123. PubMed ID: 30032256
[TBL] [Abstract][Full Text] [Related]
4. A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling.
Yu R; Wawrowsky K; Zhou C
Endocrinol Nutr; 2011; 58(6):258-66. PubMed ID: 21680267
[TBL] [Abstract][Full Text] [Related]
5. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Sipos B; Klöppel G
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37260318
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic α-cell hyperplasia: facts and myths.
Yu R
J Clin Endocrinol Metab; 2014 Mar; 99(3):748-56. PubMed ID: 24285676
[TBL] [Abstract][Full Text] [Related]
7. Glucagon receptor is required for long-term survival: a natural history study of the Mahvash disease in a murine model.
Yu R; Ren SG; Mirocha J
Endocrinol Nutr; 2012 Nov; 59(9):523-30. PubMed ID: 22951296
[TBL] [Abstract][Full Text] [Related]
8. Glucagon cell adenomatosis without glucagon receptor mutation.
Al-Sarireh B; Haidermota M; Verbeke C; Rees DA; Yu R; Griffiths AP
Pancreas; 2013 Mar; 42(2):360-2. PubMed ID: 23407487
[No Abstract] [Full Text] [Related]
9. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
10. Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.
Li M; Dean ED; Zhao L; Nicholson WE; Powers AC; Chen W
J Endocrinol; 2015 Nov; 227(2):93-103. PubMed ID: 26446275
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.
Yu R; Dhall D; Nissen NN; Zhou C; Ren SG
PLoS One; 2011; 6(8):e23397. PubMed ID: 21853126
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
13. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
[TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.
Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS
Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067
[TBL] [Abstract][Full Text] [Related]
15. Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas.
Henopp T; Anlauf M; Schmitt A; Schlenger R; Zalatnai A; Couvelard A; Ruszniewski P; Schaps KP; Jonkers YM; Speel EJ; Pellegata NS; Heitz PU; Komminoth P; Perren A; Klöppel G
J Clin Endocrinol Metab; 2009 Jan; 94(1):213-7. PubMed ID: 18957496
[TBL] [Abstract][Full Text] [Related]
16. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
Liu Q; Lin G; Chen Y; Feng W; Xu Y; Lyu J; Yang D; Wang MW
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002801
[TBL] [Abstract][Full Text] [Related]
17. Metabolic impact of glucagon deficiency.
Hayashi Y
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():151-7. PubMed ID: 21824269
[TBL] [Abstract][Full Text] [Related]
18. Crispr-Cas9 mediated complete deletion of glucagon receptor in mice display hyperglucagonemia and α-cell hyperplasia.
Yuan H; Kang Q; Li Z; Bai X; Jia J; Han D; Wu X; Li M
Biochem Biophys Res Commun; 2023 Feb; 643():121-128. PubMed ID: 36596263
[TBL] [Abstract][Full Text] [Related]
19. Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
Yu R; Chen CR; Liu X; Kodra JT
J Mol Endocrinol; 2012 Oct; 49(2):69-78. PubMed ID: 22693263
[TBL] [Abstract][Full Text] [Related]
20. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
